ESR1 and breast cancer: Triple negative (TN) breast cancers are defined as the absence of estrogen receptor (ER), progesterone receptor (PR) and HER2 expression, accounting for 10-17% of all breast carcinomas depending on the threshold used to define ER and PR positivity and the methods for HER2 assessment [13,14].